US Patent Issued to STAIDSON (BEIJING) BIOPHARMACEUTICALS on Nov. 4 for "Antibodies specifically recognizing granulocyte-macrophage colony stimulating factor receptor alpha and uses thereof" (Chinese Inventors)

ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,460,008, issued on Nov. 4, was assigned to STAIDSON (BEIJING) BIOPHARMACEUTICALS Co. LTD. (Beijing).

"Antibodies specifically recognizing granulocyte-macrophage colony stimulating factor receptor alpha and uses thereof" was invented by Pingxia Zhu (Beijing), Ran Wu (Beijing), Qingshuang Zhang (Beijing) and Qun Huang (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present application provides antibodies including antigen-binding fragment thereof that specifically recognizing Granulocyte-Macrophage Colony Stimulating Factor Receptor (GM-CSFRAlpha). Also provided are methods of making and using these antibodies."

The patent was filed on Nov. 25...